Earnings call Redcare Pharmacy reported 27% YoY organic sales growth for the first nine months, driven by 122% Rx growth in Germany and 18% non-Rx growth. Adjusted EBITDA reached €44M (2.1% margin), ...

Guardian Pharmacy Services Inc., a $1.29 billion market cap company, reported a robust fourth quarter for 2024, with a 20% increase in revenue, reaching 339 million dollars. The company, which ...

Thank you everybody and a very warm welcome from our side. Today, we would like to start off a little bit different than we do usually. So greetings from Pilsen. As announced at the beginning of ...

Guardian Pharmacy Services Inc. reported its first-quarter 2025 earnings, highlighting a significant revenue increase and a modest rise in earnings per share (EPS). The company’s revenue reached ...

Good afternoon, and we're here for our last presentation of the day, but saving the best for last, right? So we have a Guardian Pharmacy Services as our next presenter. I've got Fred Burke, the ...

Guardian Pharmacy Services reported its second-quarter earnings with a revenue increase of 15% year-over-year, reaching $344.3 million. The company’s earnings per share (EPS) stood at $0.23, aligning ...

Guardian Pharmacy Services, Inc. misses on earnings expectations. Reported EPS is $0.1548 EPS, expectations were $0.24. Operator: Good day, everyone, and welcome to Guardian Pharmacy’s Third Quarter ...

Earnings call Redcare Pharmacy reported 27.3% YoY organic sales growth in H1 2025, with adjusted EBITDA margin improving from 1.3% in Q1 to 2.6% in Q2. Management reaffirmed full-year guidance, citing ...